Why is Medinova Diagno. falling/rising?

As of 26-Sep, Medinova Diagnostic Services Ltd is experiencing a decline in its stock price, currently at Rs 38.60, which represents a decrease of 1.34 or 3.36%. The stock has been underperforming, having fallen consecutively for the last two days with a total decline of 3.84%. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a positive long-term performance, with a 3.76% return over the past year and significant gains over three and five years, the company faces challenges such as a negative book value and weak long-term fundamental strength, which contribute to its current price movement.
In the broader market context, Medinova's short-term performance has been notably worse than the benchmark, with a 1-week return of -6.99% compared to the Sensex's -2.66%. This underperformance is compounded by the company's high debt levels and flat financial results, which raise concerns among investors. Although there has been a rise in investor participation, as indicated by a 23.8% increase in delivery volume, the overall sentiment remains cautious due to the company's weak growth metrics and high PEG ratio, making it a risky investment in the current market environment.